Torsdag 29 Oktober | 09:26:01 Europe / Stockholm
Est. tid*
2027-02-08 14:00 Bokslutskommuniké 2026
2026-10-29 07:45 Kvartalsrapport 2026-Q3
2026-07-17 - Kvartalsrapport 2026-Q2
2026-05-07 - X-dag ordinarie utdelning NOLA B 1.70 SEK
2026-05-06 - Årsstämma
2026-05-06 - Kvartalsrapport 2026-Q1
2026-02-05 - Bokslutskommuniké 2025
2025-10-28 - Kvartalsrapport 2025-Q3
2025-07-18 - Kvartalsrapport 2025-Q2
2025-05-07 - X-dag ordinarie utdelning NOLA B 1.50 SEK
2025-05-06 - Årsstämma
2025-05-06 - Kvartalsrapport 2025-Q1
2025-02-07 - Bokslutskommuniké 2024
2024-10-25 - Kvartalsrapport 2024-Q3
2024-07-18 - Kvartalsrapport 2024-Q2
2024-05-07 - X-dag ordinarie utdelning NOLA B 1.50 SEK
2024-05-06 - Årsstämma
2024-05-06 - Kvartalsrapport 2024-Q1
2024-02-06 - Bokslutskommuniké 2023
2023-10-26 - Kvartalsrapport 2023-Q3
2023-07-20 - Kvartalsrapport 2023-Q2
2023-05-04 - X-dag ordinarie utdelning NOLA B 1.90 SEK
2023-05-03 - Årsstämma
2023-05-03 - Kvartalsrapport 2023-Q1
2023-02-08 - Bokslutskommuniké 2022
2022-10-27 - Kvartalsrapport 2022-Q3
2022-07-20 - Kvartalsrapport 2022-Q2
2022-05-04 - X-dag ordinarie utdelning NOLA B 1.90 SEK
2022-05-03 - Årsstämma
2022-05-03 - Kvartalsrapport 2022-Q1
2022-02-07 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-07-20 - Kvartalsrapport 2021-Q2
2021-05-12 - Split NOLA B 1:10
2021-05-05 - X-dag ordinarie utdelning NOLA B 16.00 SEK
2021-05-04 - Årsstämma
2021-05-04 - Kvartalsrapport 2021-Q1
2021-02-10 - Bokslutskommuniké 2020
2020-10-23 - Kvartalsrapport 2020-Q3
2020-07-17 - Kvartalsrapport 2020-Q2
2020-05-05 - X-dag ordinarie utdelning NOLA B 0.00 SEK
2020-05-04 - Årsstämma
2020-05-04 - Kvartalsrapport 2020-Q1
2020-02-10 - Bokslutskommuniké 2019
2019-05-09 - X-dag ordinarie utdelning NOLA B 14.00 SEK
2019-05-08 - Årsstämma
2019-02-12 - Bokslutskommuniké 2018
2018-10-24 - Kvartalsrapport 2018-Q3
2018-07-19 - Kvartalsrapport 2018-Q2
2018-04-25 - X-dag ordinarie utdelning NOLA B 12.50 SEK
2018-04-24 - Årsstämma
2018-04-24 - Kvartalsrapport 2018-Q1
2018-02-07 - Bokslutskommuniké 2017
2017-10-25 - Kvartalsrapport 2017-Q3
2017-07-19 - Kvartalsrapport 2017-Q2
2017-06-01 - Kapitalmarknadsdag 2017
2017-04-27 - X-dag ordinarie utdelning NOLA B 10.50 SEK
2017-04-26 - Årsstämma
2017-04-26 - Kvartalsrapport 2017-Q1
2017-02-08 - Bokslutskommuniké 2016
2016-12-05 - Extra Bolagsstämma 2016
2016-10-25 - Kvartalsrapport 2016-Q3
2016-07-19 - Kvartalsrapport 2016-Q2
2016-04-29 - X-dag ordinarie utdelning NOLA B 10.00 SEK
2016-04-28 - Årsstämma
2016-04-28 - Kvartalsrapport 2016-Q1
2016-02-04 - Bokslutskommuniké 2015
2015-10-28 - Kvartalsrapport 2015-Q3
2015-08-28 - Kapitalmarknadsdag 2015
2015-07-21 - Kvartalsrapport 2015-Q2
2015-04-30 - X-dag ordinarie utdelning NOLA B 8.50 SEK
2015-04-29 - Årsstämma
2015-04-29 - Kvartalsrapport 2015-Q1
2015-02-05 - Bokslutskommuniké 2014
2014-10-29 - Analytiker möte 2014
2014-10-28 - Kvartalsrapport 2014-Q3
2014-07-21 - Kvartalsrapport 2014-Q2
2014-04-29 - X-dag bonusutdelning NOLA B 4
2014-04-29 - X-dag ordinarie utdelning NOLA B 4.00 SEK
2014-04-28 - Årsstämma
2014-04-28 - Kvartalsrapport 2014-Q1
2014-02-04 - Bokslutskommuniké 2013
2013-10-25 - Analytiker möte 2013
2013-10-24 - Kvartalsrapport 2013-Q3
2013-10-03 - Kapitalmarknadsdag 2013
2013-07-19 - Kvartalsrapport 2013-Q2
2013-04-26 - X-dag bonusutdelning NOLA B 2.5
2013-04-26 - X-dag ordinarie utdelning NOLA B 3.50 SEK
2013-04-25 - Årsstämma
2013-04-25 - Kvartalsrapport 2013-Q1
2013-02-05 - Bokslutskommuniké 2012
2012-10-25 - Analytiker möte 2012
2012-10-24 - Kvartalsrapport 2012-Q3
2012-07-20 - Kvartalsrapport 2012-Q2
2012-04-25 - X-dag bonusutdelning NOLA B 2
2012-04-25 - X-dag ordinarie utdelning NOLA B 3.00 SEK
2012-04-24 - Årsstämma
2012-04-24 - Kvartalsrapport 2012-Q1
2012-02-01 - Bokslutskommuniké 2011
2011-11-28 - Kapitalmarknadsdag 2011
2011-10-26 - Kvartalsrapport 2011-Q3
2011-07-20 - Kvartalsrapport 2011-Q2
2011-04-28 - X-dag bonusutdelning NOLA B 3
2011-04-28 - X-dag ordinarie utdelning NOLA B 3.00 SEK
2011-04-27 - Årsstämma
2011-04-27 - Kvartalsrapport 2011-Q1
2011-02-01 - Bokslutskommuniké 2010
2010-10-26 - Kvartalsrapport 2010-Q3
2010-07-21 - Kvartalsrapport 2010-Q2
2010-04-29 - X-dag ordinarie utdelning NOLA B 3.00 SEK
2010-04-28 - Kvartalsrapport 2010-Q1
2010-02-01 - Bokslutskommuniké 2009
2009-10-27 - Kvartalsrapport 2009-Q3
2009-07-21 - Kvartalsrapport 2009-Q2
2009-04-28 - X-dag ordinarie utdelning NOLA B 2.75 SEK
2009-04-27 - Årsstämma
2009-04-27 - Kvartalsrapport 2009-Q1
2008-04-29 - X-dag ordinarie utdelning NOLA B 3.00 SEK
2007-04-26 - X-dag ordinarie utdelning NOLA B 2.40 SEK
2006-04-28 - X-dag ordinarie utdelning NOLA B 2.40 SEK
2005-04-28 - X-dag ordinarie utdelning NOLA B 1.75 SEK
2004-04-29 - X-dag ordinarie utdelning NOLA B 0.80 SEK
2003-05-06 - X-dag ordinarie utdelning NOLA B 0.50 SEK
2002-04-10 - X-dag ordinarie utdelning NOLA B 0.00 SEK
2001-05-03 - X-dag ordinarie utdelning NOLA B 2.00 SEK
2000-04-27 - X-dag ordinarie utdelning NOLA B 2.20 SEK
1999-04-27 - X-dag ordinarie utdelning NOLA B 1.80 SEK
1998-04-27 - X-dag ordinarie utdelning NOLA B 1.50 SEK
1997-04-28 - X-dag ordinarie utdelning NOLA B 0.75 SEK
1996-04-25 - X-dag ordinarie utdelning NOLA B 0.75 SEK
1995-04-28 - X-dag ordinarie utdelning NOLA B 0.60 SEK
1994-06-03 - Split NOLA B 1:5
LandSverige
ListaLarge Cap Stockholm
SektorIndustri
IndustriIndustriprodukter
Nolato är verksamt inom tillverkningsindustrin och fokuserar på utveckling, tillverkning och distribution av plastkomponenter och system för olika industrier. Bolagets produkter används inom sektorer som fordonsindustri, medicinteknik och konsumentelektronik. Verksamheten är global med en huvudsaklig närvaro i Europa, Nordamerika och Asien. Nolato grundades år 1938 och har sitt huvudkontor i Torekov.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Strategic acquisitions and strong organic growth for Medical Solutions

2026-10-29 07:45:00

Third quarter of 2026 in brief

  • Sales rose to SEK 2,500 million (2,342) – adjusted for currency and acquisitions, this was a 3% increase
  • Operating profit (EBITA) was SEK 254 million (281)
  • EBITA margin of 10.2% (12.0)
  • Profit after tax was SEK 172 million (215)
  • Earnings per share, basic and diluted, totaled SEK 0.64 (0.80)
  • Cash flow from operating activities increased to SEK 332 million (301)

Business area performance

Medical Solutions sales amounted to SEK 1,469 million (1,311) which, adjusted for currency and acquisitions, is an increase of a full 9%. Operating profit (EBITA) rose to SEK 166 million (159) and the EBITA margin was 11.3% (12.1). The business area saw growth in most market areas, particularly Drug delivery, driven by increased volumes of several newer products, and also In vitro diagnostics (IVD), where newer products account for the majority of the increase. Investments in expansion to support future growth are proceeding according to plan at several of our existing facilities. The acquisitions of the Dutch company Unitron and part of the Irish company Qualtech are included in the quarter on a one-month basis and have been successfully completed; the majority of their sales are included in the Drug delivery market area.

Engineered Solutions sales amounted to SEK 1,040 million (1,035); adjusted for currency and acquisitions, this was a decrease of 3%. Operating profit (EBITA) decreased to SEK 112 million (120) and the EBITA margin amounted to 10.8% (11.6). The Consumer electronics market segment exhibited stable volumes while Automotive declined sharply due to lower demand and the impact of model changes among customers. Hygiene continued to see inventory adjustments and lower sales, although volumes have stabilized sequentially. The market area Other grew; it now includes the majority of the business area’s share of the acquisition of Irish company Qualtech, which contributed on a one-month basis in the quarter.

Materials exhibited a sharp increase in volume and is contributing robust profitability. All customer segments exhibited growth and, in particular, shipment volumes for data centers/satellites, aerospace/defense, and the automotive sector increased significantly.

A one-time item of SEK 8 million for acquisition costs was charged to consolidated profit. In the previous year, profit was positively affected by a one-time item of SEK 7 million net related to an insurance claim.

First nine months of 2026 in brief

  • Group sales rose to SEK 7,311 million (7,190) – adjusted for currency and acquisitions, this was a 3% increase
  • Group operating profit (EBITA) was SEK 761 million (829)
  • The EBITA margin was 10.4% (11.5)
  • Profit after tax was SEK 522 million (626)
  • Earnings per share, basic and diluted, totaled SEK 1.94 (2.32)
  • Cash flow from operating activities increased to SEK 844 million (752)
  • Sustained strong financial position

Comments from the CEO

Anders Björklund, President and CEO of Nolato AB, commented:

Group sales increased by 7% in the third quarter. Adjusted for acquisitions and currency effects, organic growth was 3% in a persistently challenging business environment. However, we have a diversified customer portfolio and production on three continents, which generally gives us good resilience. Nevertheless, we are temporarily affected by higher prices for input goods, which was partly a reason for the EBITA margin declining to 10.2%.

Nolato continuously optimizes its business portfolio to strengthen its position in areas where we can combine technical expertise, close customer relationships and industrial scale in a global market. Through the recently completed acquisitions of Unitron and M&M Qualtech, Nolato is strengthening its capacity in electronics-intensive medical technology, systems integration and advanced manufacturing. The acquisitions broaden Nolato’s offering by adding development expertise and manufacturing of complete systems – including electronics – which strengthen Nolato’s presence in attractive, regulated segments and provide means for taking on greater responsibility in customers’ value chains. The acquisitions, which were consolidated as of September, contribute approximately SEK 600 million on an annual basis, with an EBITA margin in line with that of the Group.

Nolato’s financial position remains very strong, with net liabilities in relation to operating profit (EBITDA) of 1.0x at the end of the third quarter, providing us with continued financial flexibility.